UY28205A1 - Formulaciones farmaceuticas que comprenden un nuevo agente enmascarante de la amargura. - Google Patents
Formulaciones farmaceuticas que comprenden un nuevo agente enmascarante de la amargura.Info
- Publication number
- UY28205A1 UY28205A1 UY28205A UY28205A UY28205A1 UY 28205 A1 UY28205 A1 UY 28205A1 UY 28205 A UY28205 A UY 28205A UY 28205 A UY28205 A UY 28205A UY 28205 A1 UY28205 A1 UY 28205A1
- Authority
- UY
- Uruguay
- Prior art keywords
- pharmaceutical formulations
- masking agent
- amargura
- new masking
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
El presente invento se refiere a un nuevo agente enmascarante de la amargura para formulaciones farmacéuticas que van a aplicarse oralmente. Se encontró que ciertos tensioactivos farmacéuticamente aceptables pueden enmascarar el sabor amargo de algunos compuestos farmacéuticamente activos que saben amargos. El presente invento afecta en particular a formulaciones que comprenden epinastina o quinina.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03004191A EP1452177A1 (en) | 2003-02-27 | 2003-02-27 | Pharmaceutical formulations comprising sodium laurylsulfate as bitterness masking agent |
Publications (1)
Publication Number | Publication Date |
---|---|
UY28205A1 true UY28205A1 (es) | 2004-09-30 |
Family
ID=32748807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY28205A UY28205A1 (es) | 2003-02-27 | 2004-02-25 | Formulaciones farmaceuticas que comprenden un nuevo agente enmascarante de la amargura. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1452177A1 (es) |
JP (1) | JP4694468B2 (es) |
AR (1) | AR043412A1 (es) |
PE (1) | PE20041022A1 (es) |
UY (1) | UY28205A1 (es) |
WO (1) | WO2004075900A2 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7378082B1 (en) | 2007-11-05 | 2008-05-27 | Inspire Pharmaceuticals, Inc. | Method for treating allergic rhinitis without adverse effects |
CN101129346B (zh) * | 2007-07-23 | 2010-09-29 | 重庆康刻尔制药有限公司 | 盐酸氨溴索口腔崩解片及其制备方法 |
WO2010132662A1 (en) * | 2009-05-13 | 2010-11-18 | Relypsa, Inc. | Powder formulations of potassium-binding active agents |
EP2815747B8 (en) * | 2012-02-14 | 2018-06-27 | Kyukyu Pharmaceutical Co., Ltd. | Intraoral soluble-type film preparation |
EP2962678A1 (en) * | 2014-06-30 | 2016-01-06 | Symrise AG | Flavour and fragrance compositions comprising acetophenone derivatives |
PL3257511T3 (pl) * | 2015-02-10 | 2019-03-29 | Fujifilm Corporation | Tabletka rozpadająca się w jamie ustnej i sposób jej wytwarzania |
JP7057287B2 (ja) * | 2016-12-28 | 2022-04-19 | 富士フイルム富山化学株式会社 | 医薬組成物 |
EP3836897B1 (en) | 2018-08-17 | 2023-02-01 | Symrise AG | Compositions comprising guaifenesin and eriodictyol |
WO2020074073A1 (en) | 2018-10-09 | 2020-04-16 | Symrise Ag | Compositions comprising guaifenesin and flavour compounds containing an isovanillyl group |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4952392A (en) * | 1986-03-17 | 1990-08-28 | Peri-Oral Dental Products, Inc. | Use of periwinkle in oral hygiene |
DE19542281C2 (de) * | 1995-11-14 | 1997-12-04 | Boehringer Ingelheim Kg | Verwendung von Epinastin für die Behandlung der Migräne |
JPH09323931A (ja) * | 1996-06-04 | 1997-12-16 | Taisho Pharmaceut Co Ltd | 塩酸ロペラミド配合液剤組成物 |
JPH1025253A (ja) * | 1996-07-12 | 1998-01-27 | Kao Corp | 苦味低減化剤及び苦味低減化法 |
WO1999033489A1 (fr) * | 1997-12-26 | 1999-07-08 | Yamanouchi Pharmaceutical Co., Ltd. | Compositions medicinales a liberation prolongee |
EP1073419A4 (en) * | 1998-03-18 | 2009-03-25 | Univ Technology Corp | COMPOSITION, CONTAINING AMORPHOUS POLYMER, FOR DELAYED RELEASE. |
JPH11302189A (ja) * | 1998-04-21 | 1999-11-02 | Taisho Pharmaceut Co Ltd | 感冒用組成物 |
JPH11349492A (ja) * | 1998-06-03 | 1999-12-21 | Yamanouchi Pharmaceut Co Ltd | 苦味を低減した経口用医薬組成物および苦味低減化方法 |
US20020094345A1 (en) * | 2000-10-06 | 2002-07-18 | Sara Abelaira | Pharmaceutical compositions containing epinastine and pseudoephedrine |
US20020151541A1 (en) * | 2000-10-31 | 2002-10-17 | Michel Pairet | Pharmaceutical compositions containing tiotropium salts and antihistamines and their use |
DE10152973A1 (de) * | 2001-10-26 | 2003-05-08 | Boehringer Ingelheim Int | Neue trockene und wässrige Epinastin-Sirup-Formulierung |
-
2003
- 2003-02-27 EP EP03004191A patent/EP1452177A1/en not_active Withdrawn
-
2004
- 2004-02-21 WO PCT/EP2004/001737 patent/WO2004075900A2/en active Application Filing
- 2004-02-21 JP JP2006501918A patent/JP4694468B2/ja not_active Expired - Lifetime
- 2004-02-25 UY UY28205A patent/UY28205A1/es not_active Application Discontinuation
- 2004-02-25 PE PE2004000191A patent/PE20041022A1/es not_active Application Discontinuation
- 2004-02-27 AR ARP040100612A patent/AR043412A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004075900A3 (en) | 2004-10-21 |
WO2004075900A2 (en) | 2004-09-10 |
JP4694468B2 (ja) | 2011-06-08 |
PE20041022A1 (es) | 2005-01-18 |
AR043412A1 (es) | 2005-07-27 |
JP2006519202A (ja) | 2006-08-24 |
EP1452177A1 (en) | 2004-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1885336T3 (pl) | Kompozycja w postaci zawiesiny zawierająca substancję aktywną, poloksamerowy lub meroksapolowy surfaktant i glikol oraz zastosowanie kompozycji do wytwarzania leku do leczenia chorób oczu | |
ES2156028T3 (es) | Composiciones que contienen tetrahidrolipstatina | |
EA200700892A1 (ru) | Липосомная композиция, содержащая активное вещество для релаксации гладкой мускулатуры, получение этой композиции и ее терапевтическое применение | |
ZA200709296B (en) | Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycolotonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders | |
CR9609A (es) | Formulaciones de una sal de bupropion de liberacion modificada | |
TW200716208A (en) | Modified and immediate release memantine bead formulation | |
TNSN01130A1 (fr) | Formulations a liberation prolongee pour des secretagogues d'hormone de croissance | |
EP1246608A4 (en) | PHARMACEUTICAL PREPARATIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES WITH LOW WATER SOLUBILITY | |
WO2003072195A3 (en) | Method for administering glp-1 molecules | |
NO20025601D0 (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
NO20075660L (no) | Blanding for behandling av inflammatoriske sykdommer | |
EA200901393A1 (ru) | Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат | |
WO2006118948A3 (en) | Therapeutic compositions | |
BRPI0407181A (pt) | Formulação farmacêutica | |
UY28205A1 (es) | Formulaciones farmaceuticas que comprenden un nuevo agente enmascarante de la amargura. | |
WO2008042944A3 (en) | Non-irritating oral care formulations | |
PA8529701A1 (es) | Compuestos retinoides | |
DK1296972T3 (da) | Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer | |
TW200730190A (en) | New combination to treat liver fibrosis | |
MXPA03010054A (es) | Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos. | |
EA200600603A1 (ru) | Оральная система доставки лекарственного препарата | |
AR028448A1 (es) | Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares | |
BRPI0410044B8 (pt) | forma de dosagem contendo pantoprazol como ingrediente ativo | |
DE60311665D1 (de) | Pharmazeutische zusammensetzungen | |
DE602004012413D1 (de) | Halbfeste formulierung für die orale verabreichung des taxols |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20150514 |